rs1861270
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001372051.1(CASP8):c.-27+1279A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.732 in 152,020 control chromosomes in the GnomAD database, including 41,088 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.73 ( 41085 hom., cov: 31)
Exomes 𝑓: 0.88 ( 3 hom. )
Consequence
CASP8
NM_001372051.1 intron
NM_001372051.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.291
Publications
16 publications found
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
- autoimmune lymphoproliferative syndrome type 2BInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.81 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASP8 | NM_001372051.1 | c.-27+1279A>G | intron_variant | Intron 1 of 8 | ENST00000673742.1 | NP_001358980.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.732 AC: 111198AN: 151894Hom.: 41046 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
111198
AN:
151894
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.875 AC: 7AN: 8Hom.: 3 AF XY: 0.833 AC XY: 5AN XY: 6 show subpopulations
GnomAD4 exome
AF:
AC:
7
AN:
8
Hom.:
AF XY:
AC XY:
5
AN XY:
6
show subpopulations
African (AFR)
AF:
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
2
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
3
AN:
4
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.732 AC: 111284AN: 152012Hom.: 41085 Cov.: 31 AF XY: 0.729 AC XY: 54102AN XY: 74264 show subpopulations
GnomAD4 genome
AF:
AC:
111284
AN:
152012
Hom.:
Cov.:
31
AF XY:
AC XY:
54102
AN XY:
74264
show subpopulations
African (AFR)
AF:
AC:
32713
AN:
41480
American (AMR)
AF:
AC:
8889
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
2201
AN:
3472
East Asian (EAS)
AF:
AC:
3681
AN:
5172
South Asian (SAS)
AF:
AC:
4007
AN:
4822
European-Finnish (FIN)
AF:
AC:
7202
AN:
10498
Middle Eastern (MID)
AF:
AC:
215
AN:
294
European-Non Finnish (NFE)
AF:
AC:
50210
AN:
67988
Other (OTH)
AF:
AC:
1456
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1508
3016
4525
6033
7541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2781
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.